Boston Scientific’s BSX robust MedSurg segment, driven by endoscopy, neuromodulation and urology businesses, is poised for further growth in the upcoming quarters. The long-term prospects of the ...

In the most recent trading session, Boston Scientific (BSX) closed at $102.41, indicating a -1.37% shift from the previous trading day.

What if you'd invested in Boston Scientific (BSX) ten years ago? It may not have been easy to hold on to BSX for all that time, but if you did, how much would your investment be w ...

About Boston Scientific Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in ...

Review quarterly and annual revenue, net income, and cash flow for Boston Scientific Corp (BSX:XNYS) stock through the last fiscal year.

Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, ...

Learn about the executive team and board of directors at Boston Scientific Corp (BSX:XNYS) and review their bios and compensation over the latest fiscal years.

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options. Now, an MIT-led study of three major global cities uses a new, granular ...

Boston Scientific BSX has delivered an impressive return over the past year, with shares rallying 40.5%. The performance outpaced the industry’s 14.3% gain and the S&P 500 composite’s 12.5% rise.

News about Boston Scientific Corporation, including commentary and archival articles published in The New York Times.

In the latest trading session, Boston Scientific (BSX) closed at $106.53, marking a +1.86% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.52%. At ...